GHK-Cu 50mg

Research published in peer-reviewed literature demonstrates that GHK-Cu stimulates collagen and glycosaminoglycan synthesis in fibroblast models (Pickart et al., PMID: 6135661) and modulates the expression of over 31 skin-repair-associated genes simultaneously (Pickart & Margolina, PMID: 28101255) — making it one of the most broadly investigated copper peptides in preclinical tissue research. Hair follicle studies have further reported GHK-Cu-associated upregulation of VEGF and IGF-1 at the follicular level, alongside prolonged anagen phase duration in murine models (Kang et al., PMID: 17498910). For a comprehensive overview of the published research, see our GHK-Cu research guide.

What is GHK-Cu?

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring copper-binding tripeptide found in human plasma, saliva, and urine. Composed of three amino acids—glycine, histidine, and lysine—chelated to a copper(II) ion, GHK-Cu has a molecular weight of approximately 403.9 Da and the molecular formula C₁₄H₂₄CuN₆O₄. The peptide was first identified in 1973 by Dr. Loren Pickart during his doctoral research at the University of California, San Francisco, where he isolated an activity in human albumin that caused old liver tissue to synthesize proteins in patterns resembling younger tissue (Pickart et al., 1973).

GHK possesses an exceptionally high affinity for copper(II) ions, with a dissociation constant of approximately 10^−16.44 M, comparable to the copper transport site on serum albumin. This strong copper-binding capacity is central to its biological activity, as the copper complex readily facilitates copper uptake into cells (Pickart et al., 1980). One of the most significant aspects of GHK-Cu in anti-aging research is its age-related decline in human serum: levels average approximately 200 ng/mL at age 20 but decrease to roughly 80 ng/mL by age 60 (Dou et al., 2020). This decline closely parallels the reduction in tissue regenerative capacity observed during aging, making GHK-Cu one of the most extensively studied peptides in regenerative and anti-aging research. GHK-Cu is classified as a bioregulatory peptide and has been the subject of over 100 peer-reviewed publications spanning wound healing, skin rejuvenation, hair growth, anti-inflammatory signaling, and gene expression modulation.

Mechanism of Action

The mechanism of action of GHK-Cu is remarkably multifaceted, influencing cellular behavior through several distinct but interconnected pathways. At the molecular level, GHK-Cu functions primarily as a copper delivery vehicle, facilitating the regulated transport of copper ions into cells where they serve as essential cofactors for numerous enzymes and signaling processes (Pickart et al., 1980).

Growth Factor Modulation: Research indicates that GHK-Cu significantly upregulates the expression and secretion of several critical growth factors. Studies have demonstrated that GHK-Cu increases production of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and transforming growth factor beta-1 (TGF-β1) in both normal and irradiated fibroblasts (Pollard et al., 2005). These growth factors collectively drive angiogenesis, fibroblast proliferation, and extracellular matrix (ECM) remodeling—fundamental processes in tissue repair and regeneration.

Extracellular Matrix Synthesis: GHK-Cu stimulates the synthesis of collagen types I and III, elastin, glycosaminoglycans (including dermatan sulfate and chondroitin sulfate), and the small proteoglycan decorin (Maquart et al., 1993). Simultaneously, it modulates the activity of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs), enabling controlled ECM remodeling rather than disorganized scar formation. This dual capacity—stimulating both synthesis and regulated breakdown of ECM components—is key to GHK-Cu's role in promoting organized tissue repair (Pickart et al., 2015).

Gene Expression Regulation: Perhaps the most compelling aspect of GHK-Cu's mechanism of action is its broad influence on gene expression. Studies using the Broad Institute Connectivity Map have revealed that GHK modulates the expression of over 4,000 human genes, affecting approximately 32% of the human genome. Notably, GHK upregulates genes associated with regeneration, antioxidant defense, DNA repair, and the ubiquitin-proteasome system, while downregulating genes linked to inflammation, tissue destruction, and cancer progression (Pickart et al., 2014). GHK-Cu also suppresses NFκB signaling, a master regulator of inflammatory pathways, and reduces expression of pro-inflammatory cytokines including TNF-α and IL-6 (Pickart et al., 2012).

Antioxidant Activity: GHK-Cu exhibits potent antioxidant properties through multiple mechanisms: it increases superoxide dismutase (SOD) activity, suppresses free radical formation, blocks oxidizing iron release from ferritin, and inhibits lipid peroxidation. These combined antioxidant actions contribute significantly to its cell-protective and anti-aging effects (Pickart & Margolina, 2018).

Research Applications

Wound Healing and Tissue Regeneration

GHK-Cu is one of the most extensively studied peptides in wound healing research. In animal models, GHK-Cu has demonstrated the ability to accelerate wound closure, increase collagen accumulation, and improve the quality of healed tissue. The landmark study by Maquart et al. (1993) demonstrated that GHK-Cu produced concentration-dependent increases in dry weight, DNA, total protein, collagen, and glycosaminoglycan content in rat wound chambers. GHK-Cu attracts immune cells, endothelial cells, and fibroblasts to injury sites, initiating a coordinated repair response. Research also indicates that GHK-Cu accelerates healing of skin, gastrointestinal lining, and boney tissue (Pickart, 2008). These properties make GHK-Cu a prominent subject of study alongside other regenerative peptides such as BPC-157 and TB-500.

Skin Rejuvenation and Anti-Aging

Research on GHK-Cu's effects on skin rejuvenation has yielded substantial findings. Studies indicate that GHK-Cu increases collagen and elastin production in dermal fibroblasts, restores the skin barrier protein function, and improves skin density, firmness, and elasticity. In controlled studies on aged skin, GHK-Cu preparations have been observed to tighten loose skin, reduce fine lines and wrinkles, diminish photodamage and hyperpigmentation, and increase keratinocyte proliferation (Pickart, 2008). The peptide also stimulates glycosaminoglycan synthesis, which is critical for maintaining skin hydration and structural integrity (Pickart et al., 2015). These findings have positioned GHK-Cu as a leading research compound in the anti-aging peptide category.

Hair Growth Research

GHK-Cu has emerged as a notable compound in hair growth research. Studies suggest that copper peptides may enlarge hair follicle size, stimulate hair growth, and increase hair thickness. Research by Pyo et al. (2007) demonstrated that copper tripeptide complexes stimulate proliferation of dermal papilla cells, which are central to hair follicle function. GHK-Cu is thought to stimulate hair growth by increasing blood flow to hair follicles through VEGF upregulation, promoting dermal papilla cell proliferation, and extending the anagen (growth) phase of the hair cycle. This makes it a popular research peptide for investigators studying peptides for hair loss.

Anti-Inflammatory and Neuroprotective Research

GHK-Cu demonstrates significant anti-inflammatory properties through suppression of NFκB signaling, reduction of pro-inflammatory cytokines (TNF-α, IL-6), and inhibition of thromboxane formation. Research also highlights its potential neuroprotective applications: GHK increases nerve growth factor (NGF), neurotrophin-3, and neurotrophin-4 secretion, while modulating gene expression relevant to nervous system health (Pickart et al., 2017). Preliminary studies in aging mice suggest GHK may partially reverse cognitive impairment by targeting anti-inflammatory and epigenetic pathways (Dou et al., 2020). These findings connect GHK-Cu research to broader investigations into peptides for brain health and inflammation.

Gene Expression and Epigenetic Modulation

GHK-Cu's ability to modulate the expression of thousands of human genes has significant implications for aging research. Using the Broad Institute Connectivity Map, researchers found that GHK resets pathological gene expression patterns associated with cancer, COPD, and age-related degeneration back toward healthier profiles. Cancer-associated genes had their programmed cell death systems reset, while tissue-destructive genes were suppressed and repair-related genes were activated (Pickart et al., 2014). GHK was also found to activate genes involved in DNA repair, the ubiquitin-proteasome system (cellular waste clearance), and the TGF-β superfamily signaling pathways (Pickart & Margolina, 2018).

Published Research Studies

GHK-Cu is supported by an extensive body of published research. Below are key studies that have shaped understanding of this copper peptide:

1. Maquart FX et al. (1993) — Journal of Clinical Investigation
This foundational in vivo study used the wound chamber model in rats to demonstrate that GHK-Cu produces concentration-dependent increases in collagen, glycosaminoglycans, total protein, and DNA content. Type I and type III collagen mRNAs were significantly increased. A control tripeptide had no effect, confirming the specificity of GHK-Cu's actions (PMID: 8227353).

2. Pollard JD et al. (2005) — Archives of Facial Plastic Surgery
This study evaluated GHK-Cu's effects on growth factor production in normal and radiation-damaged human fibroblasts. Results showed that GHK-Cu accelerated fibroblast doubling times and significantly increased production of bFGF and VEGF. Irradiated fibroblasts treated with GHK-Cu achieved population-doubling times approaching those of normal untreated cells (PMID: 15655171).

3. Pickart L & Margolina A (2018) — International Journal of Molecular Sciences
This comprehensive review synthesized decades of GHK-Cu research with new gene expression data, detailing the peptide's regenerative and protective actions in skin, lung tissue, liver, and the nervous system. The paper discussed GHK-Cu's ability to upregulate collagen, elastin, and decorin synthesis while also demonstrating anti-cancer, anti-inflammatory, and DNA repair activities (PMID: 29986520).

4. Pickart L et al. (2014) — BioMed Research International
This gene-profiling study used the Broad Institute Connectivity Map to reveal that GHK can up- or downregulate over 4,000 human genes. The study demonstrated GHK's ability to reset gene expression in diseased cells from cancer and COPD patients toward healthier profiles, providing a molecular basis for its diverse biological effects (PMID: 25302294).

5. Dou Y et al. (2020) — Aging Pathobiology and Therapeutics
This study confirmed GHK-Cu's antioxidant properties and demonstrated that GHK-Cu pretreatment at concentrations of 10 nM and 10 μM significantly reduced reactive oxygen species (ROS) in hydrogen peroxide-treated WI-38 cells. Aging mice (28 months) treated with GHK at 10 mg/kg for 3 weeks showed improved learning compared to controls (PMID: 35083444).

Dosage Protocols in Research

The following information is provided for research reference purposes only. GHK-Cu is sold exclusively as a research chemical and is not intended for human use.

In Vitro Studies: Cell culture research has utilized GHK-Cu at concentrations ranging from 1 × 10⁻⁹ mol/L (1 nM) to 10 μM. Pollard et al. (2005) used a concentration of 1 × 10⁻⁹ mol/L in fibroblast culture studies. Dou et al. (2020) demonstrated significant antioxidant effects at both 10 nM and 10 μM concentrations.

In Vivo Animal Studies: In the Maquart et al. (1993) wound chamber study, GHK-Cu was administered via injection into subcutaneously implanted wound chambers in rats at varying concentrations to establish dose-response relationships. Dou et al. (2020) administered GHK intraperitoneally at 10 mg/kg body weight, 5 times per week for 3 weeks in aging mice.

Reconstitution: For research use, GHK-Cu lyophilized powder is typically reconstituted in bacteriostatic water or sterile water. Standard reconstitution protocols suggest slow addition of solvent along the vial wall, followed by gentle swirling (not shaking) to dissolve the peptide. For detailed reconstitution guidance, consult our how to reconstitute peptides guide.

Research Concentrations: Published literature references GHK-Cu concentrations ranging from nanomolar to low micromolar in cell-based assays, and approximately 0.5–10 mg/kg in animal models. Researchers should consult published protocols for their specific application.

Storage and Handling

Proper storage of GHK-Cu is essential to maintain peptide integrity and ensure reliable research outcomes. For detailed peptide storage best practices, refer to our comprehensive how to store research peptides guide.

Lyophilized (unreconstituted) form: Store at -20°C for long-term storage (up to 24 months) or at 2–8°C (refrigerated) for shorter periods up to 6 months. Protect from light and moisture. Keep vials sealed until ready for use.

Reconstituted form: Once reconstituted with bacteriostatic water, store at 2–8°C (refrigerated) and use within 4–6 weeks for optimal activity. Avoid repeated freeze-thaw cycles, as this can degrade peptide structure and reduce biological activity. Aliquoting into single-use portions is recommended for studies requiring multiple administrations.

Handling precautions: GHK-Cu is sensitive to oxidation due to its copper component. Work in a clean environment, use sterile technique during reconstitution, and minimize exposure to air. The copper complex imparts a characteristic blue-green tint to reconstituted solutions; significant color change may indicate degradation.

Safety Profile in Research

GHK-Cu has demonstrated a favorable safety profile across decades of in vitro and in vivo research. As a naturally occurring peptide present in human plasma, its endogenous nature contributes to low toxicity and high biocompatibility in studied models.

In vitro safety: Cell culture studies consistently report that GHK-Cu at concentrations used in research (nanomolar to low micromolar range) does not exhibit cytotoxic effects on fibroblasts, keratinocytes, or other cell types (Pollard et al., 2005). In fact, GHK-Cu promotes cell survival and protects cells from radiation-induced damage.

In vivo safety: Animal studies using systemic administration of GHK at doses up to 10 mg/kg body weight have not reported significant adverse effects (Dou et al., 2020). GHK-Cu has a long history of safe use in topical wound healing and skincare applications, further supporting its low-risk profile.

Known considerations: As a copper-containing compound, excessive copper delivery could theoretically contribute to oxidative stress at very high concentrations. However, GHK-Cu's self-regulating copper-binding mechanism and physiological copper concentrations used in research mitigate this concern. Researchers studying GHK-Cu should follow institutional safety protocols for handling peptides and copper compounds. For additional safety information, consult our research peptide safety guide.

Related Peptides

Researchers investigating GHK-Cu often explore complementary peptides that share overlapping applications in tissue regeneration, anti-aging, and wound healing:

BPC-157 — A pentadecapeptide derived from gastric juice that promotes wound healing and tissue repair through distinct but complementary mechanisms. While GHK-Cu works primarily through copper-mediated growth factor activation and ECM remodeling, BPC-157 operates through VEGF and NO pathways. Researchers may compare these two peptides in wound healing research protocols.

TB-500 — A synthetic fragment of thymosin beta-4 that promotes cell migration and angiogenesis. TB-500 and GHK-Cu share overlapping wound healing and anti-inflammatory pathways, making them relevant compounds for comparative tissue repair studies.

Epithalon — A tetrapeptide that activates telomerase, relevant to researchers studying anti-aging mechanisms. While GHK-Cu addresses aging through gene expression modulation and antioxidant effects, Epithalon targets cellular senescence at the chromosomal level. Read more about Epithalon anti-aging research.

KPV — An anti-inflammatory tripeptide derived from alpha-MSH. KPV and GHK-Cu both exhibit anti-inflammatory properties, though KPV acts primarily through NF-κB inhibition in immune cells and gastrointestinal tissue.

Frequently Asked Questions

What is GHK-Cu used for in research?

GHK-Cu is used in research investigating wound healing, skin rejuvenation, hair growth, anti-aging mechanisms, anti-inflammatory pathways, neuroprotection, and gene expression modulation. It is one of the most extensively studied copper peptides, with over 100 published studies examining its effects on tissue regeneration, collagen synthesis, growth factor production, and the reversal of age-related gene expression changes. For a comprehensive overview, see our GHK-Cu copper peptide guide.

How does GHK-Cu differ from GHK without copper?

GHK is the free tripeptide (glycyl-L-histidyl-L-lysine), while GHK-Cu is the copper(II) chelate complex. Both forms exhibit biological activity, but research consistently demonstrates that GHK-Cu produces stronger responses in wound healing and hair growth models compared to copper-free GHK. The copper ion is believed to be essential for many of GHK's biological effects, particularly those involving enzyme activation and cellular copper delivery.

What is the molecular weight of GHK-Cu?

GHK-Cu has a molecular weight of approximately 403.9 Da. The free tripeptide GHK (without copper) has a molecular weight of approximately 340.4 Da. The relatively small molecular size contributes to GHK-Cu's ability to penetrate tissues and interact with cellular targets effectively.

Why do GHK-Cu levels decline with age?

Research shows that human plasma GHK-Cu levels average approximately 200 ng/mL at age 20 and decline to about 80 ng/mL by age 60—a roughly 60% reduction. The exact mechanisms driving this decline are not fully understood, but it is thought to be related to age-associated changes in albumin metabolism and reduced peptide synthesis. This decline correlates with reduced regenerative capacity observed in aging tissues.

How is GHK-Cu reconstituted for research?

GHK-Cu lyophilized powder is typically reconstituted with bacteriostatic water or sterile water for injection. The solvent should be added slowly along the vial wall, and the vial gently swirled (never shaken) until the peptide is fully dissolved. Reconstituted GHK-Cu should be stored refrigerated at 2–8°C and used within 4–6 weeks. For step-by-step instructions, visit our reconstitution guide.

Can GHK-Cu be used alongside other research peptides?

In research settings, GHK-Cu is frequently studied in combination with other peptides. Its wound healing and tissue regeneration properties complement those of peptides like BPC-157 and TB-500. For information on combining research peptides, consult our guide on best peptide stack combinations.

What makes GHK-Cu unique among research peptides?

GHK-Cu is unique for several reasons: it is one of the few peptides that naturally occurs in human plasma, it modulates the expression of over 4,000 human genes, and its biological effects span an unusually wide range of tissues and systems. Unlike peptides that target a single receptor or pathway, GHK-Cu's copper-delivery mechanism and broad gene expression effects produce coordinated regenerative responses across multiple biological systems simultaneously.

Why Buy GHK-Cu from Iron Peak Peptides?

Iron Peak Peptides is committed to providing researchers with the highest quality GHK-Cu available. Every batch of our GHK-Cu 50mg undergoes rigorous third-party testing to verify purity, identity, and sterility, ensuring your research data is built on a foundation of reliable, high-quality material.

Quality Assurance: Our GHK-Cu is manufactured in cGMP-compliant facilities and verified to ≥99% purity through independent HPLC and mass spectrometry analysis. Each vial is accompanied by a quality assurance documentation detailing purity, molecular weight confirmation, and endotoxin levels.

Generous Quantity: Our 50mg vials provide ample material for extended research protocols, reducing the need for frequent reorders and ensuring consistency across experimental timelines.

Researcher Support: We provide comprehensive educational resources including our detailed GHK-Cu copper peptide guide, reconstitution instructions, and storage recommendations to support your research workflow. Our customer support team is staffed by knowledgeable specialists who understand the needs of peptide researchers.

Fast, Discreet Shipping: All orders are shipped in temperature-controlled packaging to preserve peptide integrity during transit, with free shipping available on qualifying orders.

References

1. Pickart L, Thayer L, Thaler MM. A synthetic tripeptide which increases survival of normal liver cells, and stimulates growth in hepatoma cells. Biochem Biophys Res Commun. 1973;54(2):562-566.
2. Pickart L, Freedman JH, Loker WJ, et al. Growth-modulating plasma tripeptide may function by facilitating copper uptake into cells. Nature. 1980;288(5792):715-717.
3. Wegrowski Y, Maquart FX, Borel JP. Stimulation of sulfated glycosaminoglycan synthesis by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. Life Sci. 1992;51(13):1049-1056.
4. Maquart FX, Bellon G, Chaqour B, et al. In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds. J Clin Invest. 1993;92(5):2368-2376.
5. Pollard JD, Quan S, Kang T, Koch RJ. Effects of copper tripeptide on the growth and expression of growth factors by normal and irradiated fibroblasts. Arch Facial Plast Surg. 2005;7(1):27-31.
6. Pyo HK, Yoo HG, Won CH, et al. The effect of tripeptide-copper complex on human hair growth in vitro. Arch Pharm Res. 2007;30(7):834-839.
7. Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2008;19(8):969-988.
8. Pickart L, Vasquez-Soltero JM, Margolina A. The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive health. Oxid Med Cell Longev. 2012;2012:324832.
9. Pickart L, Vasquez-Soltero JM, Margolina A. GHK and DNA: resetting the human genome to health. Biomed Res Int. 2014;2014:151479.
10. Pickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int. 2015;2015:648108.
11. Pickart L, Vasquez-Soltero JM, Margolina A. The effect of the human peptide GHK on gene expression relevant to nervous system function and cognitive decline. Brain Sci. 2017;7(2):20.
12. Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987.
13. Dou Y, Lee A, Zhu L, Morton J, Ladiges W. The potential of GHK as an anti-aging peptide. Aging Pathobiol Ther. 2020;2(1):58-61.